Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours. - Cheeseman SL; Brannan M; McGown A; Khan P; Gardner C; Gumbrell L; Dickens D; Ranson M (British journal of cancer, 2000)